CORC  > 湖南大学
Prevalence and current therapy in chronic liver disorders
Daniyal, M; Akram, M; Zainab, R; Munir, N; Sharif, A; Shah, SMA; Liu, B; Wang, W
刊名INFLAMMOPHARMACOLOGY
2019
卷号Vol.27 No.2页码:213-231
关键词Liver disorders Allopathic medicine Side effects Medicinal plants Hepatoprotective activity Efficacy Literature review
ISSN号0925-4692;1568-5608
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4748481
专题湖南大学
作者单位1.Hunan Univ Chinese Med, TCM & Ethnomed Innovat & Dev Int Lab, Sch Pharm, Innovat Mat Medica Res Inst, Changsha 410208, Hunan, Peoples R China
2.Govt Coll Univ, Dept Eastern Med, Directorate Med Sci, Faisalabad, Pakistan
3.Govt Coll Univ, Dept Biochem, Directorate Med Sci, Faisalabad, Pakistan
4.Govt Coll Univ, Coll Allied Hlth Profess, Directorate Med Sci, Faisalabad, Pakistan
5.Univ Sargodha, Dept Pathol, Fac Med & Hlth Sci, Sargodha, Pakistan
6.Hunan Univ, Hunan Prov Key Lab Plant Funct Genom & Dev Regula, Coll Biol, Changsha 410082, Hunan, Peoples R China
推荐引用方式
GB/T 7714
Daniyal, M,Akram, M,Zainab, R,et al. Prevalence and current therapy in chronic liver disorders[J]. INFLAMMOPHARMACOLOGY,2019,Vol.27 No.2:213-231.
APA Daniyal, M.,Akram, M.,Zainab, R.,Munir, N.,Sharif, A.,...&Wang, W.(2019).Prevalence and current therapy in chronic liver disorders.INFLAMMOPHARMACOLOGY,Vol.27 No.2,213-231.
MLA Daniyal, M,et al."Prevalence and current therapy in chronic liver disorders".INFLAMMOPHARMACOLOGY Vol.27 No.2(2019):213-231.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace